• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

癌症中高度突变基因的计算机分析提供了对异常 mRNA 剪接的深入了解:剪接因子 3B 亚基 1 突变体。

In Silico Analysis of a Highly Mutated Gene in Cancer Provides Insight into Abnormal mRNA Splicing: Splicing Factor 3B Subunit 1 Mutant.

机构信息

The Graduate School of Engineering and Natural Science, Istanbul Medipol University, 34810 Istanbul, Turkey.

Department of Computer Engineering, Muğla Sıtkı Koçman University, 48000 Muğla, Turkey.

出版信息

Biomolecules. 2020 Apr 28;10(5):680. doi: 10.3390/biom10050680.

DOI:10.3390/biom10050680
PMID:32354150
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7277358/
Abstract

Cancer is the second leading cause of death worldwide. The etiology of the disease has remained elusive, but mutations causing aberrant RNA splicing have been considered one of the significant factors in various cancer types. The association of aberrant RNA splicing with drug/therapy resistance further increases the importance of these mutations. In this work, the impact of the splicing factor 3B subunit 1 (SF3B1) K700E mutation, a highly prevalent mutation in various cancer types, is investigated through molecular dynamics simulations. Based on our results, K700E mutation increases flexibility of the mutant SF3B1. Consequently, this mutation leads to i) disruption of interaction of pre-mRNA with SF3B1 and p14, thus preventing proper alignment of mRNA and causing usage of abnormal 3' splice site, and ii) disruption of communication in critical regions participating in interactions with other proteins in pre-mRNA splicing machinery. We anticipate that this study enhances our understanding of the mechanism of functional abnormalities associated with splicing machinery, thereby, increasing possibility for designing effective therapies to combat cancer at an earlier stage.

摘要

癌症是全球第二大死亡原因。尽管该疾病的病因仍未明确,但导致 RNA 剪接异常的突变已被认为是各种癌症类型的重要因素之一。RNA 剪接异常与药物/治疗耐药性的关联进一步增加了这些突变的重要性。在这项工作中,通过分子动力学模拟研究了剪接因子 3B 亚基 1(SF3B1)K700E 突变的影响,该突变在各种癌症类型中非常普遍。根据我们的结果,K700E 突变增加了突变 SF3B1 的柔韧性。因此,这种突变导致:i)前体 mRNA 与 SF3B1 和 p14 的相互作用被破坏,从而阻止 mRNA 正确排列并导致异常 3' 剪接位点的使用,ii)在参与前体 mRNA 剪接机制中与其他蛋白质相互作用的关键区域的通信被破坏。我们预计,这项研究将增强我们对与剪接机制相关的功能异常机制的理解,从而增加在早期阶段设计有效治疗癌症的可能性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42e6/7277358/1b923b025244/biomolecules-10-00680-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42e6/7277358/185372a86266/biomolecules-10-00680-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42e6/7277358/a11dacaa1409/biomolecules-10-00680-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42e6/7277358/6a1cab507351/biomolecules-10-00680-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42e6/7277358/3d368e3d2731/biomolecules-10-00680-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42e6/7277358/87cb584d0f1e/biomolecules-10-00680-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42e6/7277358/ff6c18e492e8/biomolecules-10-00680-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42e6/7277358/9e63aaae520d/biomolecules-10-00680-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42e6/7277358/1b923b025244/biomolecules-10-00680-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42e6/7277358/185372a86266/biomolecules-10-00680-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42e6/7277358/a11dacaa1409/biomolecules-10-00680-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42e6/7277358/6a1cab507351/biomolecules-10-00680-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42e6/7277358/3d368e3d2731/biomolecules-10-00680-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42e6/7277358/87cb584d0f1e/biomolecules-10-00680-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42e6/7277358/ff6c18e492e8/biomolecules-10-00680-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42e6/7277358/9e63aaae520d/biomolecules-10-00680-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42e6/7277358/1b923b025244/biomolecules-10-00680-g008.jpg

相似文献

1
In Silico Analysis of a Highly Mutated Gene in Cancer Provides Insight into Abnormal mRNA Splicing: Splicing Factor 3B Subunit 1 Mutant.癌症中高度突变基因的计算机分析提供了对异常 mRNA 剪接的深入了解:剪接因子 3B 亚基 1 突变体。
Biomolecules. 2020 Apr 28;10(5):680. doi: 10.3390/biom10050680.
2
Investigating the Molecular Mechanism of H3B-8800: A Splicing Modulator Inducing Preferential Lethality in Spliceosome-Mutant Cancers.研究 H3B-8800 的分子机制:一种剪接调节剂,诱导剪接体突变型癌症的选择性致死。
Int J Mol Sci. 2021 Oct 18;22(20):11222. doi: 10.3390/ijms222011222.
3
Physiologic Expression of Sf3b1(K700E) Causes Impaired Erythropoiesis, Aberrant Splicing, and Sensitivity to Therapeutic Spliceosome Modulation.Sf3b1(K700E)的生理表达导致红细胞生成受损、异常剪接以及对治疗性剪接体调节的敏感性。
Cancer Cell. 2016 Sep 12;30(3):404-417. doi: 10.1016/j.ccell.2016.08.006.
4
SF3B1 mutation in pancreatic cancer contributes to aerobic glycolysis and tumor growth through a PP2A-c-Myc axis.胰腺癌中的 SF3B1 突变通过 PP2A-c-Myc 轴促进有氧糖酵解和肿瘤生长。
Mol Oncol. 2021 Nov;15(11):3076-3090. doi: 10.1002/1878-0261.12970. Epub 2021 May 3.
5
Characterization of the aberrant splicing of MAP3K7 induced by cancer-associated SF3B1 mutation.鉴定癌症相关 SF3B1 突变诱导的 MAP3K7 剪接异常。
J Biochem. 2021 Sep 22;170(1):69-77. doi: 10.1093/jb/mvab023.
6
Hemopoietic-specific Sf3b1-K700E knock-in mice display the splicing defect seen in human MDS but develop anemia without ring sideroblasts.造血特异性Sf3b1-K700E基因敲入小鼠表现出人类骨髓增生异常综合征(MDS)中所见的剪接缺陷,但会发展为无环形铁粒幼细胞的贫血。
Leukemia. 2017 Mar;31(3):720-727. doi: 10.1038/leu.2016.251. Epub 2016 Sep 8.
7
Cancer-associated mutations in SF3B1 disrupt the interaction between SF3B1 and DDX42.SF3B1 中的癌症相关突变会破坏 SF3B1 和 DDX42 之间的相互作用。
J Biochem. 2022 Jul 25;172(2):117-126. doi: 10.1093/jb/mvac049.
8
Disease-Causing Mutations in SF3B1 Alter Splicing by Disrupting Interaction with SUGP1.SF3B1 中的致病突变通过与 SUGP1 的相互作用破坏剪接而改变剪接。
Mol Cell. 2019 Oct 3;76(1):82-95.e7. doi: 10.1016/j.molcel.2019.07.017. Epub 2019 Aug 29.
9
Cancer-Related Mutations Alter RNA-Driven Functional Cross-Talk Underlying Premature-Messenger RNA Recognition by Splicing Factor SF3b.癌症相关突变改变 RNA 驱动的功能串扰,该串扰是剪接因子 SF3b 识别前体 mRNA 的基础。
J Phys Chem Lett. 2023 Jul 13;14(27):6263-6269. doi: 10.1021/acs.jpclett.3c01402. Epub 2023 Jul 3.
10
Impact of cancer-associated mutations in Hsh155/SF3b1 HEAT repeats 9-12 on pre-mRNA splicing in Saccharomyces cerevisiae.癌症相关突变对酿酒酵母 Hsh155/SF3b1 HEAT 重复 9-12 区前体 mRNA 剪接的影响。
PLoS One. 2020 Apr 22;15(4):e0229315. doi: 10.1371/journal.pone.0229315. eCollection 2020.

引用本文的文献

1
Structural screening and molecular simulation identify potential ligands against the K700E hot spot variant and functional pockets of SF3B1 to modulate splicing in myelodysplastic syndrome.结构筛选和分子模拟确定了针对K700E热点变体和SF3B1功能口袋的潜在配体,以调节骨髓增生异常综合征中的剪接。
Heliyon. 2024 Jun 10;10(12):e32729. doi: 10.1016/j.heliyon.2024.e32729. eCollection 2024 Jun 30.
2
Regulation of Pre-mRNA Splicing: Indispensable Role of Post-Translational Modifications of Splicing Factors.前体mRNA剪接的调控:剪接因子翻译后修饰的不可或缺的作用。
Life (Basel). 2023 Feb 21;13(3):604. doi: 10.3390/life13030604.
3

本文引用的文献

1
Disclosing the Impact of Carcinogenic SF3b Mutations on Pre-mRNA Recognition Via All-Atom Simulations.通过全原子模拟揭示致癌性 SF3b 突变对 pre-mRNA 识别的影响。
Biomolecules. 2019 Oct 21;9(10):633. doi: 10.3390/biom9100633.
2
Exploiting Cryo-EM Structural Information and All-Atom Simulations To Decrypt the Molecular Mechanism of Splicing Modulators.利用冷冻电镜结构信息和全原子模拟来破解剪接调节剂的分子机制。
J Chem Inf Model. 2020 May 26;60(5):2510-2521. doi: 10.1021/acs.jcim.9b00635. Epub 2019 Oct 3.
3
Disease-Causing Mutations in SF3B1 Alter Splicing by Disrupting Interaction with SUGP1.
The biological function and clinical significance of SF3B1 mutations in cancer.
癌症中SF3B1突变的生物学功能及临床意义
Biomark Res. 2020 Sep 3;8:38. doi: 10.1186/s40364-020-00220-5. eCollection 2020.
SF3B1 中的致病突变通过与 SUGP1 的相互作用破坏剪接而改变剪接。
Mol Cell. 2019 Oct 3;76(1):82-95.e7. doi: 10.1016/j.molcel.2019.07.017. Epub 2019 Aug 29.
4
Altered splicing and cytoplasmic levels of tRNA synthetases in SF3B1-mutant myelodysplastic syndromes as a therapeutic vulnerability.SF3B1 突变性骨髓增生异常综合征中 tRNA 合成酶的剪接改变和细胞质水平作为治疗靶点。
Sci Rep. 2019 Feb 25;9(1):2678. doi: 10.1038/s41598-019-39591-7.
5
Probing the cooperative mechanism of the μ-δ opioid receptor heterodimer by multiscale simulation.采用多尺度模拟技术探究μ-δ 阿片受体异二聚体的协同作用机制。
Phys Chem Chem Phys. 2018 Dec 5;20(47):29969-29982. doi: 10.1039/c8cp06652c.
6
Function, clinical application, and strategies of Pre-mRNA splicing in cancer.mRNA 前体剪接在癌症中的功能、临床应用及策略。
Cell Death Differ. 2019 Jul;26(7):1181-1194. doi: 10.1038/s41418-018-0231-3. Epub 2018 Nov 21.
7
Aberrant RNA Splicing in Cancer and Drug Resistance.癌症与耐药性中的异常RNA剪接
Cancers (Basel). 2018 Nov 20;10(11):458. doi: 10.3390/cancers10110458.
8
COSMIC: the Catalogue Of Somatic Mutations In Cancer.COSMIC:癌症体细胞突变目录。
Nucleic Acids Res. 2019 Jan 8;47(D1):D941-D947. doi: 10.1093/nar/gky1015.
9
Protein dynamic communities from elastic network models align closely to the communities defined by molecular dynamics.从弹性网络模型得出的蛋白质动态社区与通过分子动力学定义的社区非常吻合。
PLoS One. 2018 Jun 20;13(6):e0199225. doi: 10.1371/journal.pone.0199225. eCollection 2018.
10
Splicing dysregulation as a driver of breast cancer.剪接调控异常作为乳腺癌的驱动因素。
Endocr Relat Cancer. 2018 Sep;25(9):R467-R478. doi: 10.1530/ERC-18-0068. Epub 2018 May 30.